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Abstract
Objectives
To explore cognitive performance in chronic fatigue syndrome (CFS) examining two
cohorts. To establish findings associated with CFS and those related to co-morbid depres-
sion or autonomic dysfunction.
Methods
Identification and recruitment of participants was identical in both phases, all CFS patients
fulfilled Fukuda criteria. In Phase 1 (n = 48) we explored cognitive function in a heteroge-
neous cohort of CFS patients, investigating links with depressive symptoms (HADS). In
phase 2 (n = 51 CFS & n = 20 controls) participants with co-morbid major depression were
excluded (SCID). Furthermore, we investigated relationships between cognitive perfor-
mance and heart rate variability (HRV).
Results
Cognitive performance in unselected CFS patients is in average range on most measures.
However, 0–23% of the CFS sample fell below the 5th percentile. Negative correlations
occurred between depressive symptoms (HAD-S) with Digit-Symbol-Coding (r = -.507, p =
.006) and TMT-A (r = -.382, p = .049). In CFS without depression, impairments of cognitive
performance remained with significant differences in indices of psychomotor speed (TMT-A:
p = 0.027; digit-symbol substitution: p = 0.004; digit-symbol copy: p = 0.007; scanning: p =
.034) Stroop test suggested differences due to processing speed rather than inhibition.
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Both cohorts confirmed relationships between cognitive performance and HRV (digit-
symbol copy (r = .330, p = .018), digit-symbol substitution (r = .313, p = .025), colour-naming
trials Stroop task (r = .279, p = .050).
Conclusion
Cognitive difficulties in CFS may not be as broad as suggested and may be restricted to
slowing in basic processing speed. While depressive symptoms can be associated with
impairments, co-morbidity with major depression is not itself responsible for reductions in
cognitive performance. Impaired autonomic control of heart-rate associates with reductions
in basic processing speed.
Introduction
Chronic fatigue syndrome (CFS) is a chronic debilitating condition that affects at least 0.2–
0.4% of the UK population and is life changing [1,2]. Despite this there are currently no diag-
nostic tools beyond symptom recognition and no curative treatments [2]. Almost 90% of those
with CFS describe cognitive abnormalities, including poor concentration, memory loss, an
inability to take in information, and a general reduction in cognitive ability [3–8]. Although
these studies have identified a number of cognitive deficits, they are often of small magnitude
and involve multiple domains, so no consistent profile has been identified across studies. How-
ever, a meta-analysis [9] and a recent review [10] suggest that those with CFS experience cog-
nitive difficulties particularly in domains of attention, memory and motor speed.
Clinical heterogeneity across cohorts may explain the observed differences in the pattern
and magnitude of cognitive deficits in CFS. Neuropsychiatric symptoms are often present in
CFS, with the prevalence of major depression (MDD) being particularly high [11,12]. In MDD
cognitive deficits have been observed in the same domains implicated in CFS, namely atten-
tion, executive function, memory and motor speed [13, 14]. Therefore an important step to
accurately characterise cognitive deficits in CFS is to address this major confound. Previous
evidence regarding the role of depressive symptoms in the cognitive deficits of CFS has been
mixed, with some [8, 15] but not all [16, 17] studies showing a relationship.
One area that has received relatively little attention thus far is the possible role of autonomic
nervous system dysfunction in the cognitive problems in CFS. Autonomic signs and symptoms
are commonly [18], but not universally [19, 20], reported and may be an important compo-
nent of the aetiology of CFS. Heart-rate variability (HRV) is a measure of cardiovascular auto-
nomic control with lower HRV indicating reduced autonomic function [21]. One previous
study has shown that CFS patients with lower HRV also showed poorer function in several
neurocognitive tasks [16] particularly memory and attention/processing speed.
In the current study we explored potential deficits in cognitive performance in CFS. We
performed studies in two separate cohorts of CFS patients. Identification and recruitment of
CFS participants was identical in both phases, with all patients fulfilling Fukuda criteria [22]
for CFS. In the first cohort we explored cognitive function in a heterogeneous cohort of conse-
cutive patients attending a CFS clinical service, which allowed us to investigate the potential
link with depressive symptoms. In contrast, in cohort two participants with co-morbid major
depression were rigorously excluded. The purpose of these two cohorts was to allow us to
establish which findings were associated with CFS and which were related to co-morbid
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depression. Furthermore, we investigated the relationship between cognitive performance and
HRV in these cohorts of CFS in an attempt to replicate earlier findings in this area [16].
Methods
Cohort 1: Exploring cognitive performance in an unselected cohort of CFS
patients
Participants. Forty eight consecutive CFS patients were recruited as part of an ME
Research UK funded project via the Newcastle upon Tyne Royal Victoria Hospital clinical
Chronic Fatigue Syndrome Service. All fulfilled the Fukuda diagnostic criteria [22] applied by
the same Physician. Consecutive patients were provided with a Patient Information Sheet and
invited to contact the research team if they were willing to be involved. Participants were not
selected positively or negatively according to any criteria other than the fact that they were
attending the clinical service and had a Fukuda diagnosis of CFS. All participants gave written,
informed consent prior to participation and the study was approved by the Newcastle and
North Tyneside NHS Research Ethics Committee.
Neuropsychological assessment. All participants performed of the following neuropsy-
chological tests with a trained operator (RP):
Intellectual Function was measured with the Wechsler Abbreviated Scale of Intelligence
(WASI) [23] to derive a full-scale intelligence quotient (IQ) as a summary of overall cognitive
ability. This is a standardized assessment and established short form of the Wechsler Adult
Intelligence Scale (WAIS-III). It assesses vocabulary comprehension, visuoconstructive ability
(block design), verbal reasoning (similarities) and nonverbal deductive reasoning (matrices).
Raw scores are compared with population age and sex normative values, resulting in a T score
that is standardized to a mean of 50 and a standard deviation of 10.
Verbal Memory was assessed with the Logical Passages Test from the Wechsler Memory
Scales III (WMS-III; [24]). This assesses immediate and delayed verbal declarative recall of a
passage read once to the participant.
Visual Memory was assessed with the Family Pictures test from the WMS-III, which mea-
sures immediate and delayed visual memory. The test involves recalling the details from visu-
ally presented scenes both immediately and after a delay.
Verbal Working Memory was assessed with Digit Span (WAIS-III) [25], which requires
the participant to recall verbally presented sequences of numbers in either forwards or reverse
order. The task requires attention, concentration, working memory, mental control, and
reasoning.
Executive Function was assessed with 1) Verbal Fluency [26], which requires the partici-
pant to generate as many words as possible in one minute that begin with a given letter and
accord to certain rules. 2) The Trail-Making Test (TMT; [27], which is a test of complex visual
scanning and which requires a combination of information processing speed, manual motor
speed, and sustained attention. Part B requires participants to alternate between connecting
numbers and letters, thus involving additional category switching and executive functions.
Psychomotor Speed was assessed with three different tests. 1) Symbol Search (WAIS-III),
which requires visual scanning to identify whether target nonsense symbols appear in an array
and to complete as many as possible in a given time limit. 2) Digit Symbol Coding (WAIS-III),
which involves visual scanning, paired associates learning and fine-grained motor responses in
order to use a key to draw nonsense symbols under their paired digit, completing as many as
possible in a given time limit. 3) Part A of the TMT which requires participants to draw lines
connecting consecutively numbered circles as quickly as possible.
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Depressive symptom assessment. Depressive symptoms were assessed with the Depres-
sion subscale of the Hospital Anxiety and Depression Scale (HADS-D) [28], a clinician rated
instrument to determine the level of anxiety and depression on a scale from 0 to 21 respec-
tively. These were available for 25 of the 48 CFS participants, as this was a multi-component
study and not all participants took part in each component.
Assessment of autonomic function using heart-rate variability. Continuous ECG
recordings were taken during a supine-rest period of 10-minutes using the Task Force Moni-
tor (CNSystems Medizintechnik AG, Graz, Austria) system in 46 of the 49 participants. Conse-
cutive R-R intervals were recorded by the system and analysed using the RHRV toolbox [29].
The R-R interval time series was first filtered to remove intervals that were either too short or
too long. A linear analysis of the filtered time series then computed the root-mean-square of
successive differences (RMSSD) as a global measure of HRV and which has also been reported
[16].
Data analysis. The performance of the CFS patients was compared with the standardised
norms available for each test. Clinically, performance below the 5th percentile is typically an
indicator of a significant deficit. Average percentile performance and percentage of the sample
performing below the 5th percentile are reported. The relationship between neuropsychologi-
cal performance and depressive symptoms was examined by Pearson correlations. The rela-
tionship between neuropsychological performance and HRV was examined by Person
correlation with log-transformed RMSSD values, which showed a skewed distribution in their
original values. Statistical analyses were conducted using SPSS version 21.
Cohort 2: Exploring cognitive performance in CFS where depression is not
a confounder
The general recruitment procedures were identical to cohort 1. Participants were recruited as
part of a Medical Research Council-funded observational study aimed at understanding the
pathogenesis of autonomic dysfunction in patients with chronic fatigue syndrome.
Participants. Patients (n = 51) were not selected positively or negatively according to any
criteria other than the fact that they were attending the clinical service and had a Fukuda diag-
nosis of CFS. However, in this cohort patients were excluded if they screened positive for a
major depressive episode as assessed by a trained Physician using the Structured Clinical Inter-
view for the Diagnostic and Statistical Manual for Mental Disorders (version IV; SCID-IV
[30]).
Controls (n = 20) were recruited via advertisement in the local hospital and University,
together with a distribution of posters via the local ME Patient Support Group where the
relatives of those with CFS were invited to participate. Controls were considered to be com-
munity controls rather than healthy controls, i.e. they fulfilled the same inclusion and exclu-
sion criteria as CFS participants other than the fact that they did not have a CFS diagnosis.
All participants gave written, informed consent prior to participation and the study was
reviewed and approved by the Newcastle NHS ethics committee (REC 12/NE/0146, CLRN
ID 97805).
Neuropsychological assessment. The following battery of neuropsychological assess-
ments were performed by a trained clinician in the clinical research facility.
Psychomotor Speed was assessed nearly identically to study 1 using the Trail Making
Test—see above for details, and the Digit Symbol Substitution Test (DSST), a modified version
of the Digit Symbol Coding test [31], which alongside the standard version of the task also
includes control conditions for motor speed (Digit Symbol Copy) and scanning efficiency
(Digit Symbol Scanning).
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Intellectual Function was assessed with the National Adult Reading Test (NART; [32])
which requires the participant to correctly pronounce a list of irregularly spelled words. It
gives an estimate of premorbid IQ.
Verbal Learning and Memory was assessed with the Rey Auditory Verbal Learning Test
[33], which involves recall of a word list presented multiple times and assesses both immediate
recall, learning and recall after a 30minute delay.
Verbal Working Memory was assessed with Digit Span (WAIS-III) [25], which requires
the participant to recall verbally presented sequences of numbers in either forwards or reverse
order. The task requires attention, concentration, working memory, mental control, and
reasoning.
Spatial Working Memory was assessed with the “Blocks” test of the WAMI-III which gives
forward and backward spatial span measures similar to the Digit Span in the verbal domain.
Visual Working Memory was assessed with the Visual Patterns Test [34] which assesses
short term recall of matrices of white and black squares that become increasingly complex.
Executive Function was assessed with the Stroop Colour-Word Test [35] which requires
participants to say aloud the colour of the ink in which a colour-related word is printed (e.g.
the word ‘red’ printed in green ink). This requires mental control and inhibition.
Heart rate variability assessment. Measurement and calculation of HRV was identical to
the procedures of cohort 1, but were restricted to the patient group only.
Data analysis. The CFS and control groups were compared with independent samples t-
tests using bias corrected and accelerated bootstrapping (with a resampling value of 1000 and
the Mersenne Twister seed set to 200). The alpha level was set to 0.05. Where Levene’s test for
unequal variances indicated unequal variances, the appropriate adjustment to the degrees of
freedom and p-value were used. Effect sizes were calculated using Cohen’s d and were trans-
formed such that a positive effect size indicates better performance by the control group. The
relationship between neuropsychological performance and HRV in the patient group was
examined by Person correlation with log-transformed RMSSD values, which showed a skewed
distribution in their original values. Statistical analyses were conducted using SPSS version 21.
Results
Phase 1: Exploring cognitive performance in an unselected cohort of CFS patients
Demographic details and scores on the neuropsychological assessment for study 1 are
shown in Table 1. Characterising the group using age-standardised scores shows performance
in the average range on most of the measures (the average percentile rank does not differ
markedly from 50 and falls within 1 standard deviation of the mean for all tests; i.e. 16th to 84th
percentile). However, after calculating the proportion of CFS patients at or below the 5th per-
centile it was observed that between 0 and 23% of the CFS sample fall within this range across
all test indices (Table 1).
Relationship with depressive symptoms
Of the 25 patients who completed a battery of self-report questionnaires as part of this multi-
component study, 11 patients met the HADS cut-off score for depression. There were no sig-
nificant differences in age (t57 = 1.49, p = 0.141), gender (χ
2
1 = 0.037, p = 0.848) or neuropsy-
chological test performance for those who completed the HADS compared to those who did
not (all t<1.90, all p>0.05). Similarly there were no significant differences in age (t23 = -0.95,
p = 0.352) and gender (χ21 = 0.032, p = 0.859) between those that scored above and below the
cut-off. Scores for tests that showed a proportionally higher than expected percentage of
patients falling below the 5th percentile of the age-standardized score were correlated with
Cognition in chronic fatigue syndrome is unrelated to depression
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HADS-D scores. Significant negative correlations were found with Digit-Symbol-Coding
(r = -.507, p = .006) and TMT-A (r = -.382, p = .049).
Relationship with HRV
Log-transformed RMSSD values correlated positively with both the raw (r = .425, p = .004)
and scaled (r = .311, p = .038) scores of the WAIS-III symbol search task, and positive with the
raw score of the WAIS-III symbol substitution task (r = .347, p = .018) but not the scaled score
(r = .224, p = .135). It correlated negatively with time taken on the TMT-B (r = -.309, p = .039).
Phase 2: Exploring cognitive performance in CFS where depression is not a confounder
Demographic details and scores on the neuropsychological assessment are shown in Table 2.
There were significant differences between the groups in several indices of psychomotor speed
(Trail making test part A, time to complete: Cohen’s d = 0.65, p = 0.027; digit-symbol substitu-
tion, symbols per minute: d = 0.78, p = 0.004; digit-symbol copy: d = 0.80, p = 0.007; digit-sym-
bol scanning: d = 0.67, p = .034); verbal learning (delayed verbal recall: d = 0.49, p = 0.041); and
executive function (Stroop colour-word trial number correct: d = 0.74, p = 0.002). Comparing
performance of the groups on the two control indices of the Stroop test (word reading and
Table 1. Phase 1 demographics and neuropsychological test performance.
Patients (n = 48) Patients vs norms
Mean s.d. Percentile % below 5th percentile
Demographics
Age 44.9 12.3 - -
Gender (%F) 89.6 - - -
HADS-D score 8.9 4.5 - -
Cognitive function
Verbal Memory
Immediate—Logical Memory 1 9.6 3.4 46.8 10.4�
Delayed—Logical Memory 2 9.9 3.4 48.7 8.3
Visual Memory
Immediate—Family Pictures 1 8.6 2.9 37.2 18.8��
Delayed–Family Pictures 2 8.7 a 3.3 40.1 19.1�
Intellectual Function
Block Design 55.7 9.2 67.4 2.1
Matrix Reasoning 57.1 8.4 71.8 2.1
Vocabulary 54.8 8.1 65.0 0
Similarities 52.8 6.8 59.1 0
Estimated Full scale IQ 109.3 12.3 68.3 0
Symbol Search 10.2 a 2.2 52.2 0
Digit Symbol Coding 9.1 2.8 41.3 10.4�
Digit Span 11.3 2.9 60.1 0
Psychomotor Speed
Trail Making Test A 35.7a 14.9 38.9 21��
Executive Function
Trail Making Test B 69.9 a 25.8 41.9 23��
Verbal Fluency 43.1 12.5 63.0 2.1
a n = 47 due to missing data
�above expected ratio (p < .1)
��above expected ratio (p < .01)
https://doi.org/10.1371/journal.pone.0210394.t001
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colour naming) showed significant differences, which suggests differences on the colour-word
trial were likely due to speed of processing rather than difficulties with inhibition.
Relationship with HRV
Log-transformed RMSSD values correlated positively with digit-symbol copy (r = .330, p =
.018) and digit-symbol substitution (r = .313, p = .025). It further correlated positively with
performance on the colour-naming trials of the Stroop task (r = .279, p = .050). No other cor-
relation of RMSSD with neuropsychological measures reached statistical significance.
Discussion
Our study suggests consistent cognitive impairments in CFS which is shown in both cohorts,
including cohort 2 in which patients with depression had been rigorously excluded.
Table 2. Phase 2 demographics and neuropsychological test performance.
Patient Control
Mean s.d. Mean s.d. Mean difference (95%CI) p d
Demographics
Age 46.0 11.9 44.8 16.5 -1.11 (-9.19,6.80) 0.785
Gender (%F) 75% - 65% - χ2 = 0.642 0.423 -
Premorbid IQ
NART 117.9 7.9 117.5 9.2 -0.41 (-4.79,3.93) 0.851 -0.05
Verbal Memory
Digit Span forwards 6.8 1.4 6.6 1.5 -0.16 (-0.59,0.92) 0.676 -0.12
AVLT total recall (trails 1–5) 46.9 10.4 49.4 7.9 2.46 (-1.78,6.1) 0.281 0.25
AVLT recall after interference (A6) 9.6 3.3 10.7 2.4 1.06 (-0.30,2.36) 0.125 0.34
AVLT delayed recall (A7) 9.1 3.2 10.7 2.7 1.51 (0.06,3.01) 0.041� 0.49
AVLT recognition (list A hits) 12.4 2.5 12.9 2.3 0.44 (-0.86,1.65) 0.477 0.18
Visual Memory
Visual Patterns Test total score 22.5 5.9 23.5 6.4 1.03 (-2.17,4.20) 0.559 0.17
Spatial Memory
Spatial Span forwards 5.1 1.5 5.6 1.7 0.50 (-1.35,0.36) 0.229 0.33
Spatial Span backwards 4.9 1.2 5.0 1.2 0.08 (-0.61,0.71) 0.828 0.06
Executive Function
Verbal Fluency (total correct) 39.3 10.6 44.8 12.2 5.50 (-0.19,11.06) 0.075 0.50
Stroop Colour-Word trial (total correct) 37.9 12.4 46.9 11.8 9.02 (2.44,15.35) 0.006� 0.74
Stroop Interference score 2.5 8.3 2.8 9.1 -0.24 (-5.04,4.92) 0.926 -0.03
Digit Span backwards 5.0 1.3 5.4 1.2 0.42 (-0.23,0.99) 0.186 0.34
Trail Making Test B 63.9 37.1 55.2 20.1 -9.15 (-21.69,2.97) 0.236 0.31
Trail Making Test B-A 32.9 23.1 33.1 19.2 0.17 (-9.29,11.16) 0.977 -0.01
Psychomotor Speed
Trail Making Test A 30.6 17.4 22.2 6.4 -8.47 (-15.00,-3.30) 0.027� 0.65
Digit-Symbol Substitution (1/min) 35.2 9.5 42.7 9.8 7.52 (2.78,13.25) 0.004� 0.78
Digit-Symbol Copy (1/min) 67.5 18.9 82.7 19.7 15.24 (5.22,24.70) 0.007� 0.80
Digit-Symbol Scanning (1/min) 37.9 8.6 45.5 13.6 7.55 (1.69,14.24) 0.034� 0.67
Stroop Colour Reading (total correct) 84.2 25.0 104.3 14.6 20.06 (11.07, 29.09) 0.001� 0.98
Stroop Colour Naming (total correct) 61.6 17.0 76.4 11.3 14.71 (8.01,21.52) 0.001� 1.02
�Statistically significant result
https://doi.org/10.1371/journal.pone.0210394.t002
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That cognitive impairment correlated with the depression scale score in cohort 1 but was
still present in cohort 2 is interesting and perhaps suggests that depression explains some but
not all of the cognitive impairment in CFS. Cohort 1 used the HADS scale which is commonly
used in CFS populations [36–38], however, its ability to discriminate between general disease
burden and core affective symptoms has not been established; this is exemplified by the ques-
tion “I feel as if I am slowed down”-. It is a limitation of the study that sub-threshold depressive
symptoms were not recorded in cohort 2. In a previous study, correlations between depression
and attention and between depression and executive function disappeared once overall fatigue
severity was statistically accounted for; however, a correlation between depression and verbal
memory remained [8].
Taken together, our two cohorts suggest an impairment in psychomotor speed, with
reduced performance in various measures of memory. Cohort 1 showed three memory indices
with an elevated proportion of patients with clinically significant reductions in performance.
In cohort 2 only one memory measure (delayed free recall) showed significantly weaker per-
formance in the patient group compared to the control group. This suggests that memory defi-
cits in CFS are less consistent and may perhaps depend on the exact nature of the tasks used to
assess memory function.
The consistent evidence in these two cohorts of reduced psychomotor speed suggest a gen-
eral slowing of either basic perceptual-cognitive processes, basic motor responses or both. The
finding that the largest effect sizes are seen in sub-tests that should make minimal cognitive
demands, such as the symbol copy of the digit-symbol task and the two control conditions of
the Stroop task, support the hypothesis that the core neuropsychological deficits in CFS may
mostly be related to slow processing speed. Such slowing could potentially account for deficits
in other tasks that require speeded responses. A meta-analysis and a recent systematic review
have shown that general slowing of processing speed in attention tasks in CFS patients is a con-
sistent finding and shows the largest effect size when comparing CFS patients to healthy volun-
teers [9, 10]. It is further clear from our findings that such slowing cannot be explained by
potential co-morbid major depression although depressive symptoms may exacerbate the pro-
cessing speed deficit.
A further finding that is consistent with a previously published study [16] is the association
between a measure of resting HRV and indicators of psychomotor speed in the variants of the
digit-symbol task. While additional associations of cognitive tasks with HRV have been found
in our two cohorts and in the previous study, only the digit-symbol task has consistently pro-
duced significant correlations with RMSSD in all three samples. Given the correlative nature
of these findings and that we did not apply error correction to these analyses one of course has
to be cautious when interpreting them. The findings do suggest however that CFS patients
with larger processing-speed deficits tend to also be patients who exhibit reduced autonomic
control of cardiovascular function. How these two deficits are linked remains unknown. One
possible scenario is that both are caused by a common underlying disease process. Beaumont
and colleagues [16], for instance, proposed chronic loss of inhibitory control by the prefrontal
cortex as a possible cause for both the reduced autonomic function and the impaired cognitive
function, and characterized CFS as a potential “state of physiological hyper-vigilance”. How-
ever, whereas Beaumont and colleagues showed significant associations between HRV and all
of their neurocognitive tasks (digit symbol, spatial working memory, Stroop) [16], in our two
cohorts we only found consistent associations with the digit symbol task, and only isolated and
inconsistent associations to the other tasks. Thus, it is not clear how the proposed model
would explain an apparent specificity to measures of processing speed. Neuroinflammation is
an alternative common pathophysiological process for both the ANS dysregulation and the
cognitive impairment. Cognitive difficulties in CFS have recently been associated with brain
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measures of neuroinflammation [39] particularly in sub-cortical brain structures such as the
thalamus and amygdala. Both of these structures have been implicated in basic cognitive func-
tion, particularly attention, and central autonomic control. However, as the above study used
self-reported measures of cognitive (dys)function it is unclear how these might relate to objec-
tive measures of cognitive performance, as there is no clear relationship between subjectively
reported cognitive problems and objective, laboratory based measures of cognitive function in
CFS [9].
The fact that the current studies found only limited evidence for broad neurocognitive
impairment in CFS may seem surprising given the suggestion that neurocognitive dysfunction
is one of three core symptoms that are present in about 95% of CFS patients [40]. The above
mentioned lack of relationship between subjectively reported and objectively measured cogni-
tive difficulties may account for this apparent discrepancy [9]. Laboratory based measures of
cognition may not fully capture the degree with which patients are (or perceive themselves to
be) cognitively impaired in everyday life. Methodological differences have also been hypothe-
sized as a potential source for discrepancies in findings between studies [10]. Tasks that require
speeded responses may be more sensitive to an underlying (core) deficit in processing speed,
and may therefore be more likely to show differences between CFS patients and controls.
This study has a number of limitations. Measures of symptom severity and education levels
may impact upon cognitive performance and should be considered in future research. Cohort
1 and 2 described depressive symptomatology using different tools and although the staged
approach to our protocol allowed associations to be considered it does not allow direct testing
of a hypothesis. CFS remains a poorly defined heterogenous condition with subjective diag-
nostic criteria, research to characterise CFS phenotypes is needed.
Conclusion
This study showed that cognitive difficulties in CFS may not be as broad as sometimes sug-
gested and may instead be restricted to a slowing in basic processing speed, with potential fol-
low-on effects on other cognitive domains (depending on specific test parameters). While
depressive symptoms can be associated with these impairments, co-morbidity with major
depression is not itself responsible for these reductions in cognitive performance. In addition,
the present study provided further evidence that impaired autonomic control of heart-rate is
associated with reductions in basic processing speed, although how exactly these two findings
are linked remains unknown.
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